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Abstract 
BACKGROUND: Pregelatinizing is processed to modify structure of starch by heating a certain temperature. 
Increasing of temperature causes the starch to absorb water and swell quickly in order to obtain a larger particle 
size. Larger particle size will improve the flowability and compressibility of the granules. Pregelatinized taro starch 
is used as diluent tablets with wet granulation method. 
AIM: The objective research was to determine the effect of increasing pregelatinized taro starch temperature as 
diluent on compressibility and comprimability granule of thiamine hidrochloride compression.  
METHODS: Pregelatinized taro starch is made by heating the suspension of starch at 50°C, 60°C and 70°C for 
10 minutes and then dried. Pregelatinized taro starch is used as a filler of Thiamine Hidrocloride tablets which 
made by wet granulation method. Test wereperformed for each formula such as quality tests of granules and 
tablets physical properties and assay. 
RESULT: Granule compressibility evaluation results show that the formula 1, 2, and 3 qualified with 
compressibility value is 7.9941 respectively; 6.9929; and 5.9950%. From the results of the one-way ANOVA 
analysis of the compressibility obtained sig. 0,000 less than 0.05, then there is a significant difference between 
formula one with the other formulas. 
CONCLUSION: It shows the difference in temperature affect the compressibility pregelatinized taro starch. The 
higher the temperature of pregelatinized taro starch, produces tablets with low compressibility. 
 
 
 
 
 
Introduction 
 
Excipients are pharmaceutical additives, the 
inactive ingredients used to make up a medication. 
They include dyes, flavors, binders, emollients, fillers, 
lubricants, preservatives, and many more 
classifications. Common excipients used as fillers 
include starch [1], [2]. The filler material is the material 
used in the manufacture of tablets that are intended 
for weight, tablet size as required, to assist in making 
tablets, and to improve the quality of tablet 
preparations [3]. 
To provide satisfactory performance in a 
tablet dosage form, a diluent should be [4]: 1. Inert so 
as not to cause pharmacological activity of its own; 2. 
Compatible with the drug substance and other 
excipients used in the formulation; 3. Non-hygroscopic 
so the formulation does not absorb significant 
amounts of moisture from its surroundings; and 4. 
Compactable and of similar particle size to the active 
ingredient. 
Starch is one of the most abundant natural 
carbohydrates stored in plants. It is found in many 
different plant organs including seeds, fruits, tubers 
and roots, functioned as a source of energy. Although 
starch is idespread, abundantly available, cheap, 
degradable, pollution-free and renewable, it has many 
short falls, i.e., insoluble in cold water, easy to 
dehydration, low emulsifying power and unstable in 
acid, due to which commercial application is limited.3 
A survey of the literature shows that the usefulness of 
starches from various botanical sources as 
pharmaceutical excipients [4]. Starches are widely 
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available and have been very useful in tablet 
production due to their inertness, cheapness and 
utilization as fillers, binders, disintegrants and glidants 
[5]. 
However, the use of starch is limited by it poor 
functional properties of flow, compressibility and 
compatibility. Several modifications have been shown 
to improve these functional properties [6]. Modified 
starches, also called starch derivatives, are prepared 
by physically, enzymatically or chemically treating 
native starch, thereby changing the properties of the 
starch. The different types of modifications include 
heat gelatinization, enzymatic hydrolysis, acid 
hydrolysis and other various forms of chemical 
modifications [7]. 
Pregelatinization is a process of changing the 
structure of starch both physically and chemically, by 
heating the starch suspension at a temperature of 62-
72°C [8]. The temperature at the which gelatinization 
of a starch occurs. The gelatinization temperature is 
dependent upon such factors as starch concentration, 
pH of the suspension, rate of heating, the presence of 
certain salts, and the specific procedure being 
followed. Under well-defined conditions, starches can 
be classified using gelatinization temperature as a 
means for differentiation. The properties of the starch 
granule are dependent upon the arrangement of the 
bonds which link glucose units to one-another within 
the starch molecule itself [9]. 
The starch used for making pregelatinized 
starch is taro starch (Colocasia esculenta (L.) Schott). 
Taro have abundant productivity, but the utilization of 
taro has not been explored to its full potential. 
Utilization of clashes in rural communities is limited to 
frying or steaming. The community does not know 
much about the advantages of taro which have 
bioactive compounds that can be used as functional 
food [10]. Carbohydrate levels found in taro tubers 
were 88.03%. Carbohydrates consist of fraction of 
starch and crude fiber. Both of these fractions are 
important parts that can be used as bioactive 
components of taro [11]. 
The increasing use of heat causes the 
hydrogen bond between amylose and amylopectin to 
weaken so that the starch granule absorbs water and 
expands rapidly to obtain a larger particle size. Larger 
particle size will improve the flow and compressibility 
properties of granules. Partial pregelatinized starch is 
usually used for tablet formulations as fillers with 
concentrations of 5-75%, binders with a concentration 
of 5-20% and crushers with concentrations of 5-10%. 
Pregelatinization is made by heating the starch 
suspension containing water not less than 42% by 
weight of starch at a temperature of 62-72°C [8]. 
At this temperature difference whether it will 
affect the compressibility and compatibility of the 
thiamine hydrochloride tablet formulation produced. 
Compressibility and compatibility affect the 
manufacturing process of tablets, the smaller the 
percentage of compressibility, the easier the print 
mass is compressed, while the compatibility is powder 
or granules to be compressed into tablets.In this study 
3 formulas were used with a temperature increase of 
pregelatinized taro starch (Colocasia esculenta (L.) 
Schott) ie 50, 60 and 70°C. 
 
 
Material and Methods 
 
Material  
Oven (Memmert), single punch tablet 
machine, friability tester (Guoming CS-2), 
desintegration tester (BJ-2), hardness tester (Min hua 
YD-3), tapped density tester, granule flow tester, 
analytic scale (Ohaus), multilevel sieve, stopwatch, 
UV-Vis spectrophotometer (Shimadzu UV-1601), 
volumetric flask, volume pipette, waterbath (Eyela 
OSB-2100), crucible, desiccator and other glassware. 
Thiamine hydrochloride, taro starch, PVP, 
talc, magnesium stearate, primojel, and aquadest, 
iodine solution, HCl solution, ethanol. 
 
Examining the characteristics oftaro 
 starch 
The examination included organoleptic, 
organoleptic analysis was carried out by observing the 
shape, color, and odor. Iodine reaction, loss on drying 
and residual annealing. 
 
Pregelatinized taro starch 
Taro starch was weighed approximately 500 
grams, then suspended in water in a ratio of 1: 4 (500 
grams of starch in 2.0 liters of water). Then the 
suspension is heated over the waterbath at a 
predetermined temperature, ie 50, 60, and 70°C for 10 
minutes, until it produces thick starch or starch 
suspension. After obtaining starch suspension from 
each temperature, the suspension was dried with a 
dryer used, ie oven at ± 50°C for 48 hours. The results 
obtained are smoothed using mortar and stamper to 
become fine powder. After that the powder is sieved 
with a mesh 30 sieve. The aggregated taro amylum is 
stored in a dry and clean container [12]. Furthermore, 
the aggregated taro starch was tested for flow time 
and angle of repose. 
 
Formulation of Thiamine Hidrocloride 
 Tablets 
Thiamine hydrocloride tablets are prepared by 
wet granulation method. Each formula is prepared 
with a segregated taro starch at different 
temperatures. The formula can be seen from Table 1. 
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Table 1: Formula of Thiamine Hidrocloride tablets 
Material 
Formula (%) 
F1 F2 F3 
Thiamine Hidrocloride 25 25 25 
PVP 3 3 3 
Primogel 5 5 5 
Talc 1 1 1 
Mg stearate 0.5 0.5 0.5 
Pregelatinized taro starch at 50
0
C ad 100 - - 
Pregelatinized taro starch at 60
0
C ad - 100 - 
Pregelatinized taro starch at 70
0
C ad - - 100 
 
Tablets are made with wet granulation 
method. After the raw material is weighed, the inner 
phase is mixed, namely thiamine hydrochloride and 
pregelatinized taro starch. Then the binder is made by 
dissolving PVP with 96% alcohol until it dissolves. 
Then the binding in several phases in many parts can 
create a mass that can be clenched and can be 
broken but not destructive. The wet mass that has 
been homogeneous is sieved with sieve No. 16, then 
dried at a temperature of 50-60°C, then sieved with 
sieve No. 20. Then enter the outer phase, namely 
primojel, mg stearate, and talc into a dry granule, mix 
until homogeneous. evaluation include granule flow, 
angle of repose, particle size distribution, 
compressibility, compatibility and compactibility and 
granule loss on drying. The granule is pressed into a 
tablet. The tablets produced were evaluated in the 
form of Organoleptic test, size uniformity, weight 
uniformity, hardness, friability, disintegration time, 
assay and uniformity. 
 
 
Results  
 
The used taro starch was was obtained from 
Indonesian Spice and Medicinal Crops Research 
Institute (ISMCRI).  
Table 2: Characteristics of Taro starch 
No. Evaluation Result Standard 
1. 
Organoleptic:   
a.Shape a. powder  
b.Odor b.Odorless - 
c.Taste c.Tasteless  
d. Colour d. Beige  
2. Loss on drying 9.42% < 15% [13] 
3. Sisapemijaran 0.43% < 0.6% [13] 
4. Iodine reaction + (dark blue) dark blue 
 
The evaluation of taro starch was carried out 
to test the characteristics of taro starch in accordance 
with the literature.  
Table 3: The evaluation result of granule 
Evaluation F1 F2 F3 Standart 
Loss in drying (%) 5.1157 5.0331 5.1314 2-4% [14] 
Granule flow tester 
(second) 
7.3 8.1 7.3 ≤ 5 detik [14]
 
Angle of repose (°) 31.42 30.09 28.49 25-45° [14]
 
Compressibility (%) 7.9941 6.9929 5.9950 < 20% [14] 
 
The evaluations carried out included 
organoleptic, chemical reactions, drying losses and 
residual spawning. 
 
Figure 1: Granule size distribution 
 
 
 
Discussion 
 
Organoleptic tests were carried out to 
determine the shape, color, taste and aroma of taro 
starch using the five senses. The results obtained 
from taro starch have the form of powder, creamy, 
tasteless and odorless. 
Tablе 4: The evaluation result of Compatibility 
Punch drop on (mm) 
Hardness (kg) 
Compactibility 
F1 F2 F3 
0 - - - - 
1 - - - - 
2 0 0 0 - 
3 0.02 0.04 0.07 - 
4 0.02 0.05 0.05 - 
5 0.13 0.15 0.13 - 
6 0.21 1.72 1.85 - 
7 5.75 6.18 6.22 Compact and shiny 
 
In the qualitative test of the identification of 
starch, Taro starch which has been suspended into 
water and then heated to form a colloidal solution 
which is then cooled shows a dark blue color change 
if reacted with iodine, this color change is reversible 
which blue color will disappear when reheated. This 
reaction shows positive powder containing starch. 
Table 5: The evaluation result of tablets  
Evaluation F1 F2 F3 Standart 
Diameters (cm) 0.80 0.80 0.80 
11 / 3 thick tablets < 
diameter < 3 times the 
thickness of the tablet
 
[13] 
Thickness (cm) 0.22 0.31 0.31 - 
Hardness (kg) 4.96 6.02 4.35 4-8 kg [15] 
Friability (%) 0.2904 0.2168 0.3763 ≤ 1% [13] 
Disintegration (minute) 6.39 5.30 5.49 < 15 menit [13]
 
uniformity (% deviation) 2.4149 1.5277 1.5192 7.5-15% [13] 
assay (%) 98.28 98.68 100.77 90-110% [13] 
uniformity (RSD) 1.90 1.85 3.08 ≤ 6% [13] 
 
Loss on drying (LOD) test is carried out to 
determine the amount of part of the substance that 
evaporates. The results of the LOD test is 9.42%. The 
value meets the starch LOD requirements according 
to the Indonesian Pharmacopoeia, which is not more 
than 15% [13]. The remaining test results of the 
annealing are 0.43%, according to the standard that 
the remaining spawning permitted based on the 
Indonesian pharmacopoeia is not more than 0.6% 
stated on manihot starch. 
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Figure 2: Wavelage Thiamine Hidrocloride Curva  
 
Preparation of pregelatinized taro starch is 
carried out first in orientation to the ratio of taro starch 
and water, namely 1: 1, 1: 2, 1: 3, and 1: 4 with 
pregelatination temperatures of 50, 60, 70, and 80°C 
above wate rbath for 10 minutes, which then filtered 
and dried in an oven at 50°C for 48 hours. Then the 
aggregated starch formed is crushed and sieved with 
30 sieves. The orientation results at 80°C in all 
comparisons have formed a gel. So that this 
temperature cannot be used. So, the temperature 
used in this study is the temperature of 50, 60, 70°C in 
the ratio of taro starch and water is 1: 4. A ratio of 1: 4 
was chosen because it produced more amount of 
pregelatinized taro starch. 
Evaluations carried out included the flow 
properties of pregelatinized taro starch compared to 
the flow properties of taro starch. The results of taro 
starch and pregelatinized taro starch did not have 
good flow properties. Because when tested, the 
powder of starch starch and pregelatinized taro starch 
does not flow (compressed) and the angle of repose 
cannot be measured because the fall of the powder 
spreads irregularly. 
The evaluated taro starch is then modified to 
pregelatinized taro starch which will be used as a filler 
for thiamine hydrochloride tablets with wet granulation 
method. The composition of the tested tablet formula 
contained the same levels of active substances and 
excipients, but the difference lies in the pregelatinizing 
temperature used from each formula, namely 50, 60, 
and 70°C with the aim to determine the effect of the 
increasing pregelatinizing temperature of taro starch. 
In this study wet granulation method was 
used because wet granulation is the widest method in 
making tablets, producing more homogeneous 
granules and almost all types of active substances 
can be processed by wet granulation methods. The 
process of making granules begins by weighing 
thiamine hydrochloride and pregelatinized taro 
starchuntil homogeneous as the inner phase. PVP 
binder was dissolved in 96% ethanol as much as 5 ml 
until the dissolved PVP was complete and then added 
to the inner phase and added to aquadest until a 
banana breaking mass was formed which then carried 
out wet sifting by passing the tablet mass at sieve no. 
16, This sifting aims to reduce the particle size so that 
the ingredients can be evenly mixed during 
granulation with the desired particle size distribution. 
Then drying is done which aims to remove the binding 
solvent that has been added before so as to produce 
dry granules. Furthermore, it was dried in an oven at 
50°C for 18-24 hours to remove the solvents used in 
the formation of lumps and to reduce moisture. After 
drying, the granules are sifted back with screen 
number 20. The size is then sieved again with 20 
sieves. The sieve used depends on the diameter of 
the punch to be used. The outer phase to be used is 
primojel, mg stearate, and talc added to the dry 
granule then stirred until homogeneous and granulate 
evaluation. 
Granule evaluation includes granul flow 
tester, angle of repose, particle size distribution, 
compressibility, compatibility and compactibility. This 
evaluation is important because the properties of 
granules can affect the tablets produced. Generally, 
good granule properties can produce good tablets. 
The results of the evaluation of loss on drying 
(LOD) do not meet the requirements. The LOD of 
granular drying is 2-4%. This happens because the 
resulting granule contains a lot of water. The High 
value of LOD can interfere with the granule flow, while 
drying losses that are too small can make the granule 
crisp or brittle. 
The results of the evaluation of the flow rate 
of thiamine hydrochloride tablet granules from the 
three formulas did not meet the requirements of less 
than 5 seconds. This is related to the condition of 
moist granules. Then an evaluation of the stationary 
angle is carried out. The smaller the silent angle that 
is formed, the better the flow properties. Judging from 
the stationary angle produced, the flow properties of 
the three formulas are still good because they are less 
than 45° [3] properties are also determined by the 
compressibility value. Compressibility is an important 
stage in making tablets. The smaller the percentage of 
compressibility, the better the flow properties and the 
easier the granules are compressed into tablets. All 
formulas have a compressibility percentage that 
meets the requirements, but granule formula 3 has a 
good compressibility percentage, which is 5,995 from 
other formula granules. The terms of the 
compressibility percentage with very good grades are 
< 15%. Flow properties are very important because 
they relate to the uniformity of filling mold space which 
will affect uniformity of weight and will ultimately affect 
the uniformity of the active substance content [14]. 
The particle distribution test is intended to 
determine the particle size and particle dispersion. 
The size and dispersion of the particles need to be 
known because this can affect the flowing properties 
of the powder which can affect the average weight of 
the tablet, variations in tablet weight, granule 
crispness, and granular flowability. The test results of 
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particle size distribution of all granule formulas 
scattered on no mesh sieve 30. A good size 
distribution of curves follows the normal curve of the 
bell-shaped particle size distribution, where the 
number of large particles and small particles is equal 
and the number of particles is the most. The test 
results show that the particle size distribution of the 
third formula granule does not follow the normal curve 
because the number of granules left behind is more 
stored than in the no mesh 60 sieve. 
The next granule test is the test of 
compatibility. Tests are carried out to determine the 
ability of the powder to be printed into a tablet. From 
the granulability comparability test data on all formulas 
have good compatibility because the 2 mm punch 
reduction has been formed into a tablet with a 
hardness of 0 kg (F = 2), but at the maximum 
emphasis on tablet hardness in formula 3 is higher 
than formula 1 and 2, namely amounting to 6.22 kg. 
This is probably due to the fact that granules in 
formula 3 have a high bulk density, because the 
higher the bulk density, the higher the hardness of the 
tablet. And the upper punch drop can only be done up 
to 7 mm. At 7 mm punch decrease visually seen the 
physical shape of the tablet is compact and shiny. 
Organoleptic evaluation of tablets is important 
to control tablet appearance uniformity, consumer 
acceptance, and to monitor the correct manufacturing 
process. Evaluation is done by observing the shape, 
color, odor and taste. The evaluation results showed 
that all three tablet formulas did not have organoleptic 
differences. This implies that the effect of temperature 
in making this pregelatinized starch does not affect 
the organoleptic of the tablet. In evaluating tablet size 
uniformity, the evaluation results obtained show that 
all three formulas meet the requirements of 
Indonesian Pharmacopoeia. 
Tablet hardness is affected by the pressure 
applied during the printing process and the nature of 
the material being compressed. In general, the greater 
the pressure, the tablet produced will be harder and 
harder, although granular properties can also affect 
tablet hardness. The hardness of the tablet greatly 
affects the fragility and disintegration time of the 
tablet, the higher the hardness of the tablet, the longer 
the time of destruction. Tablet hardness obtained from 
formula 1 to 3 is 4.96; 6.02; 4.35 kg., Formulas 1 to 3 
meet the tablet requirements of 4-8 kg [15]. 
The test of friability and disintegration time of 
the tablet useful to determine tablet resistance to 
shocks that occur during the manufacturing process, 
packing, transportation, to use by consumers. The 
greater the percentage friability value, the greater the 
value of the lost tablet life. The evaluation results of 
the fragility test of the three formulas met the 
requirements, which is less than 1% [3]. While the 
tablet crush test determines whether the tablet can be 
destroyed in a certain time when placed in a liquid 
medium in certain experimental conditions [16]. 
According to the Indonesian Pharmacopoeia the 
requirements for time-out tests for tablets are not 
coated not more than 15 minutes (900 seconds). 
Based on the results of uniformity of weight, 
no more than 2 tablets deviate greater than 7.5% and 
none deviate greater than 15%, so it can be stated 
that all four formulas meet the requirements for weight 
uniformity in the Indonesian Pharmacopoeia III 
edition. The uniformity of the weight of the tablet 
depends on the flow rate of the granule from the 
hopper to the mold space. 
In the assay determination test in each 
formula so that obtained thiamine HCl levels in 
formula 1 = 98.28%; formula 2 = 98.68%; and formula 
3 = 100.77%. The calculation of the level 
determination was carried out with the linear 
regression value made with 2% HCl media in 
accordance with what was stated in the Indonesian 
Pharmacopoeia. Followed by testing the uniformity of 
thiamine hydrochloride tablet content, the results 
obtained show that all tablets of each formula meet 
the requirements of Indonesian Pharmacopoeia, 
namely the relative standard deviation of thiamine 
hydrochloride is less than 6%. The level of thiamine 
hydrochloride per tablet is within the range of 
Indonesian Pharmacopoeia requirements, ie not less 
than 90.0% and not more than 110% of the amount 
stated on the label. The content uniformity obtained 
from the three formulas ranged from 100.7041-
104.1134%. The variation in the level of active 
substances in the tablet is influenced by several 
factors, including mixing factors that are less 
homogeneous and the flow properties of the powder 
from hopper to die.  
Furthermore, data from the evaluation of 
compressibility is analyzed by data. Statistical 
analysis uses one-way ANAVA and is followed by the 
Honestly Significant Differences (Tukey HSD) test. In 
testing the normality and homogeneity of 
compressibility data obtained sig value greater than 
0.05, the data is normally distributed and 
homogeneous, so that the analysis can be continued 
with one-way analysis of variance (ANAVA). From the 
results of one-way ANAVA analysis on compressibility 
obtained sig values. 0,000 is less than 0.05. This 
shows that there are significant differences between 
formulas so that it must be continued with the Tukey 
test. Based on the results of ANAVA testing showed 
that the pregelatinizing temperature difference affects 
compressibility. The data then continued with Tukey 
testing with a 95% confidence level or significance 
ifikasi = 0.05. The Tukey test was conducted to see 
more clearly the meaningful differences in each 
formula. The test results on compressibility in 
formulas 1, 2 and 3 showed that there was an effect of 
increasing the pregelatination temperature on the 
compressibility of thiamine hydrochloride tablets. 
In conclusion, based on the results of the 
research that has been done, it can be concluded that 
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an increase in the temperature of pregelatinized taro 
starch can reduce the compressibility of thiamine 
hydrochloride tablet formulations. The higher the 
temperature of pregelatinized taro starch used, the 
lower the compressibility, so that it can be seen that at 
a temperature of 50-70°C it indicates that there is a 
decrease in compressibility. The effect of this 
temperature can accelerate the formation process of 
pregelatinized starch. From the three formulas shows 
that the compressibility value meets the requirements 
of each is 7.9941; 6,9929; and 5.9950%. While the 
value of the comparability of each formula has a value 
of F = 2, meaning that the value of the compatibility is 
formed at a decrease in the upper punch by 2 mm. 
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